Andy Weymann
InvestorVenture Partner, Frontiers in Health & Bio Investments at Verve Ventures
Küssnacht am Rigi, Schwyz, Switzerland
Writes $1.1M – $2.2M checks
About
Andy Weymann, an MD/MBA with CMO and Global Head of Clinical Strategy experience including Smith & Nephew, bridges founders, regulators, clinicians and acquirers through C-suite, board and venture work.
Invests in
AI & Machine LearningClimate TechDeep TechHardwareHealthtechRobotics
Experience
- BeCapioChairman of the Boardcurrent2024 — present
- SolasCureChairman of the Boardcurrent2023 — presentCambridge, England, United Kingdom
- GelmetixCEO and Director of the Boardcurrent2020 — presentManchester Area, United Kingdom
- JellagenChairman of the Board of Directorscurrent2023 — presentCardiff, Wales, United Kingdom
- VirtaMedDirector Board Of Directorscurrent2021 — presentZurich, Switzerland
- Hyalex Orthopaedics Inc.Senior Medical Advisorcurrent2020 — present
- 30 TECHNOLOGYSenior Medical Advisorcurrent2020 — present
- Smith& NephewChief Medical Officer and Senior Vice President Scientific, Clinical and Medical Affairs2012 — 2020Baar
- Smith& NephewDirector Board Of Directors2019 — 2020
- Smith& NephewDirector Board Of Directors2017 — 2020Baar, Zug, Switzerland
- Smith& NephewVice President Medical Education Global2006 — 2012
- AO FoundationManaging Director AO Education1997 — 2006
- Spital DavosResident (orthopedics, trauma, sports medicine)1995 — 1997Davos
- Schulthess Clinic ZurichResident (orthopedics)1994 — 1995Zurich, Switzerland
Education
- Harvard Business SchoolAudit Committees in a New Era of Governance, Corporate Board Program2021
- Harvard Business SchoolCompensation Committees: New Challenges, New Solutions2021
- Harvard Business SchoolMaking Corporate Boards More Effective, Cooperate Boards2019 — 2020
- University of Rochester - Simon Business SchoolMBA, Executive MBA2000 — 2002
- University of ZurichDoctor of Medicine (M.D.), Medicine1988 — 1994
- Kantonsschule Zürcher OberlandHigh school, High school exams1982 — 1988
- Primary School1974 — 1980
Skills & more
Non-Executive Director1Board Level3BiotechnologyMedical Devices99Orthopedic99Surgery91Medical Education63Healthcare53Product Launch50Hospitals44Clinical Research42Orthopedics43
+12 more
FDASports MedicineMarket DevelopmentBusiness StrategyClinical TrialsMarketing StrategyCommercializationCompetitive AnalysisLeadershipStrategic PlanningStrategyManagementLanguages English · French · German · Spanish
- Advanced Coperate Director Seminar — Harvard Business School Executive Education
From Andy's professional profile.
Same school
Also attended Harvard Business School1,777
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins
+ 1,771 more
Also attended University of Rochester - Simon Business School20
Camila VieiraPartner, Head of Brazil at QED InvestorsDeepali NangiaPartner at SpeedinvestWei JiangFounder & Managing Partner at CatchLight Capital PartnersTim JonesPartner at ICISurya ManthaManaging Partner at Capria VenturesEric BallFounding General Partner at Impact Venture Capital
+ 14 more
Also attended University of Zurich60
Christoph FreiPartner, Head of Energy at Emerald Technology Ventures AgDavid FischerInvestor at FELIX CAPITALJohannes ClaussSerial Entrepreneur, Investor and Mentor at tokentus investment AGMartin ScherrerPartner & Head of Managed Funds at RedstonePatrik BrudererCFO at CV LabsMoritz MüllerInvestment Analyst at SET Ventures
+ 54 more
Shared employers
Also worked at SolasCure2
Also worked at Gelmetix1
Also worked at 30 TECHNOLOGY1
Colleagues at Verve Ventures
Friederike Reinl
Partner, Head of Investor Relations at Verve Ventures
Lucas Laib
Partner, COO at Verve Ventures
Lukas Weber
Partner, CEO at Verve Ventures
Mike Hobmeier
Partner, Head Asset Management & Products at Verve Ventures
Romeo Bütler
Partner, CIO at Verve Ventures
Steffen Wagner
Partner, CEO at Verve Ventures
Thomas Meier
Partner, Head of Resilience in Energy & Resources Investments at Verve Ventures
Xavier Mesnier
Partner, Head of Frontiers in Health & Bio Investments at Verve Ventures











%20(4).avif)











